Beam Therapeutics Inc. BEAM
Set alert
26.74 USD +0.87 +3.36%
As of Nov 3, 11:03 AM ET
25.99 Day range 27.20
20.23 52-week range 38.26
- YTD
- -3.54%
- 1 year
- +10.27%
- Open
- 26.26
- Prev close
- 25.87
- Mkt cap
- 2.76B
- Vol
- 248.26K
- Avg vol
- 1.84M
- EPS
- -0.68
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 25.99
- High
- 27.20
- Forward P/E
- -5.45
- Beta
- 2.22
- Short ratio
- 13.87
- Inst. own
- 107.81%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 3, 2026
- 50-d avg
- 25.93
- 200-d avg
- 28.14
- 1y target
- 49.38
1m chart
Built from the cached one-day intraday bars.
Events in this range
- Nov 3, 2026Earnings: —; estimate -1.15; surprise —%
Signals (4)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Nov 3, 9:52 AM | 1 hour ago |
| SMA: Bearish | Nov 3, 9:47 AM | 1 hour ago |
| SMA: Bullish | Nov 3, 9:44 AM | 1 hour ago |
| SMA: Bearish | Nov 3, 9:42 AM | 1 hour ago |
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 49.38 +84.7% upside
Now 26.74
- Target (low)
- 26.00
- Target (mean)
- 49.38
- Target (high)
- 80.00
Ratings (0m) 15 13 buy · 2 hold · 0 sell
- Strong buy1
- Buy12
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 15
- 1 month ago 15
- 2 months ago 15
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.17 | -1.28 – -1.05 | -1.10 | -6.4% | 9.96M | +2.7% | 13 |
| Next quarter | -1.19 | -1.34 – -1.06 | 2.33 | -151.0% | 11.57M | -89.9% | 13 |
| Current year | -4.46 | -4.76 – -4.24 | -0.81 | -450.1% | 53.22M | -61.9% | 14 |
| Next year | -4.75 | -5.72 – -3.56 | -4.46 | -6.6% | 60.92M | +14.5% | 14 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 29, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 28, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Oct 15, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 14, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| Sep 9, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| Aug 25, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 8, 2026 | B of A Securities | Reiterated | Buy | Buy |
| Jul 7, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 13, 2026 | Bernstein | Maintained | Outperform | Outperform |
| Mar 26, 2026 | Citigroup | Maintained | Buy | Buy |
| Feb 25, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Feb 25, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Feb 20, 2026 | Canaccord Genuity | Initiated | — | Buy |
| Jan 21, 2026 | Bernstein | Maintained | Outperform | Outperform |
| Jan 7, 2026 | UBS | Initiated | — | Neutral |
| Nov 24, 2025 | Evercore ISI Group | Initiated | — | Outperform |
| Oct 10, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 9, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Sep 15, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 6, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| May 7, 2025 | Guggenheim | Maintained | Buy | Buy |
| May 7, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| May 7, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Apr 7, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 28, 2025 | B of A Securities | Upgrade | Neutral | Buy |
| Mar 12, 2025 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Mar 10, 2025 | Scotiabank | Upgrade | Sector Perform | Sector Outperform |
| Mar 10, 2025 | Jones Trading | Upgrade | Hold | Buy |
| Mar 10, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 3, 2025 | Scotiabank | Maintained | Sector Perform | Sector Perform |